New NHS Procurement Model Shifts Focus From Price to Patient Outcomes

Key Takeaways

• NHS adopts value‑based procurement, prioritizing outcomes over price
• Essity expects better patient dignity and reduced long‑term costs
• Incontinence care costs £5.13 bn (~$6.5 bn) annually in the UK
• Pilot projects show lower product usage and higher staff satisfaction
• 71% of clinicians say better product fit boosts patient independence

Pulse Analysis

The NHS’s transition to value‑based procurement reflects a broader industry trend of moving beyond headline price tags toward holistic cost‑effectiveness. Traditional tendering often rewards the lowest bid, ignoring downstream expenses such as complications, staff workload and patient readmissions. By embedding clinical outcomes, patient experience and total system cost into evaluation criteria, the NHS aims to capture hidden savings that can alleviate the chronic budget strain of a publicly funded health system.

Incontinence care illustrates the potential upside. With roughly 14 million Britons experiencing urinary leakage, the sector accounts for an estimated £5.13 bn (≈$6.5 bn) in annual spend. Essity’s TENA line, designed for comfort and fit, could reduce product waste, lower leak incidents and diminish associated infections. Early pilots reported measurable drops in product usage and heightened confidence among both patients and caregivers, suggesting that higher‑quality supplies can translate into tangible fiscal benefits and improved quality of life.

If the VBP model proves successful, it may become a template for other therapeutic areas, from wound care to chronic disease management. However, scaling the approach requires robust data infrastructure, clear outcome metrics and stakeholder alignment across commissioners, clinicians and suppliers. As the NHS refines its procurement analytics, the market will likely see increased competition on value propositions rather than price alone, reshaping supplier strategies and potentially driving innovation across the health‑care supply chain.